MTOR and Parkinson disease: The classic mTOR inhibitor, rapamycin, acted as a positive control of autophagy induction, and Sinemet® and Madopar®, which are widely used in clinical practice (Chen and Xie, 2018a), acted as positive controls for the treatment of PD.